ENSYSCE BIOSCIENCES, INC. Other Current Assets
ENSYSCE BIOSCIENCES, INC. (ENSC) had Other Current Assets of $20.55 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-08-13
- 2026-06-30: Other Assets, Current $20.55K.
- 2026-03-31: Other Assets, Current $25.55K.
- 2025-12-31: Other Assets, Current $20.55K; Other Assets, Current as first filed $18.00K.
- 2025-09-30: Other Assets, Current $68.13K.
| Period end | Other Assets, Current | Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $20.55K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $25.55K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $20.55K 10-Q · filed 2026-08-13 | $18.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | $68.13K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $241.03K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $222.70K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $18.00K 10-K · filed 2026-03-30 | |
| 2024-09-30 | $18.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $64.42K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $25.51K 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $18.00K 10-K · filed 2025-03-10 | |
| 2023-09-30 | $8.00K 10-Q · filed 2023-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |